MDxHealth SA - Ordinary shares, no par value (MDXH)
CUSIP: B5950S113
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Ordinary shares, no par value
- Shares outstanding
- 53,676,425
- Total 13F shares
- 2,690,019
- Share change
- +1,037,534
- Total reported value
- $6,187,043
- Price per share
- $2.30
- Number of holders
- 6
- Value change
- +$2,386,328
- Number of buys
- 2
Quarterly Holders Quick Answers
What is CUSIP B5950S113?
CUSIP B5950S113 identifies MDXH - MDxHealth SA - Ordinary shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP B5950S113:
Top shareholders of MDXH - MDxHealth SA - Ordinary shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MVM Partners LLP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
26,337,924
|
$105,351,696 | — | 04 Nov 2021 | |
| Bleichroeder LP |
13F
13D/G
|
Company |
15%
from 13D/G
|
7,378,333
|
$26,340,649 | — | 31 Dec 2025 | |
| EXACT SCIENCES CORP |
13D/G
|
Genomic Health, Inc. |
12%
|
6,441,171
|
$22,608,510 | $0 | 09 Jan 2026 | |
| AWM Investment Company, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
5,221,282
|
$18,639,977 | — | 31 Dec 2025 | |
| MVM Partners, LLC |
3/4/5
13F
|
Director · Company |
8.8%
|
4,700,457
|
$16,968,649 | — | 18 Mar 2026 | |
| Laurence W. Lytton |
13D/G
|
LYTTON LAURENCE W |
6.4%
|
3,163,286
|
$14,709,280 | -$3,655,360 | 30 Sep 2025 | |
| Eric Bednarski |
3/4/5
|
Director |
8.8%
|
4,700,457
|
$10,576,028 | — | 18 Mar 2026 | |
| Samjo Management, LLC |
13F
|
Company |
2.6%
|
1,395,950
|
$4,983,542 | — | 31 Dec 2025 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
2.6%
|
1,378,941
|
$4,922,819 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
498,245
|
$1,778,735 | — | 31 Dec 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
395,380
|
$1,411,507 | — | 31 Dec 2025 | |
| FreeGulliver LLC |
13F
|
Company |
0.59%
|
317,894
|
$1,134,882 | — | 31 Dec 2025 | |
| Mink Brook Asset Management LLC |
13F
|
Company |
0.49%
|
263,420
|
$940,409 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.47%
|
250,100
|
$892,857 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.46%
|
246,998
|
$881,783 | — | 31 Dec 2025 | |
| Panoramic Capital, LLC |
13F
|
Company |
0.44%
|
238,668
|
$852,045 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.36%
|
194,097
|
$692,923 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.32%
|
170,631
|
$609,153 | — | 31 Dec 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.32%
|
170,500
|
$608,685 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
116,831
|
$417,087 | — | 31 Dec 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.2%
|
107,623
|
$384,214 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.18%
|
99,183
|
$354,084 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
95,112
|
$339,550 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.17%
|
92,078
|
$328,719 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
84,402
|
$301,315 | — | 31 Dec 2025 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.14%
|
75,126
|
$268,200 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.13%
|
70,896
|
$253,000 | — | 31 Dec 2025 | |
| Calamos Advisors LLC |
13F
|
Company |
0.13%
|
67,452
|
$240,804 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.12%
|
64,978
|
$231,971 | — | 31 Dec 2025 | |
| Michael McGarrity |
3/4/5
|
Chief Executive Officer, Director |
0.18%
|
95,000
|
$213,750 | — | 18 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
56,536
|
$201,834 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.1%
|
55,658
|
$198,699 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.09%
|
48,473
|
$173,049 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
47,991
|
$171,328 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.09%
|
46,011
|
$164,259 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.08%
|
40,860
|
$145,870 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.07%
|
38,800
|
$138,516 | — | 31 Dec 2025 | |
| Delta Investment Management, LLC |
13F
|
Company |
0.06%
|
30,930
|
$110,420 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
29,185
|
$104,190 | — | 31 Dec 2025 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.05%
|
27,000
|
$96,390 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
24,949
|
$89,068 | — | 31 Dec 2025 | |
| Tidal Investments LLC |
13F
|
Company |
0.04%
|
23,887
|
$85,277 | — | 31 Dec 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
23,305
|
$83,199 | — | 31 Dec 2025 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.04%
|
22,625
|
$80,772 | — | 31 Dec 2025 | |
| Lighthouse Investment Partners, LLC |
13F
|
Company |
0.04%
|
20,513
|
$73,231 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.04%
|
19,058
|
$68,037 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
14,341
|
$51,197 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
13,854
|
$49,459 | — | 31 Dec 2025 | |
| Lido Advisors, LLC |
13F
|
Company |
0.02%
|
10,339
|
$48,076 | — | 31 Dec 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.02%
|
10,925
|
$39,002 | — | 31 Dec 2025 |
Institutional Holders of MDxHealth SA - Ordinary shares, no par value (MDXH) as of Q1 2026
As of 31 Mar 2026,
MDxHealth SA - Ordinary shares, no par value (MDXH) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,690,019 shares.
The largest 6 holders included
PERKINS CAPITAL MANAGEMENT INC, Mink Brook Asset Management LLC, Cambridge Investment Research Advisors, Inc., Monetary Solutions, Ltd, SBI Securities Co., Ltd., and Farther Finance Advisors, LLC.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
56
Q1 2026 holders
6
Holder diff
-50
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.